Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2015-08-01 to 2022-07-31
Current total value of award: $1581194.95
Description: ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER:  A RANDOMIZED PRESURGICAL TRIAL